Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

The effect of tactile-kinesthetic stimulation on growth indices of healthy neonates.

Abedi F, Mirbagher Ajorpaz N, Esalatmanesh S, Rahemi Z, Gilasi HR, Kafaei Atrian M, Hosseinian M.

J Bodyw Mov Ther. 2018 Apr;22(2):308-312. doi: 10.1016/j.jbmt.2017.08.005. Epub 2017 Aug 18.

PMID:
29861224
2.

Trends of Mental Health Status in Iranian Population Aged 15 and above between 1999 and 2015.

Noorbala AA, Bagheri Yazdi SA, Faghihzadeh S, Kamali K, Faghihzadeh E, Hajebi A, Akhondzadeh S, Esalatmanesh S, Bagheri Yazdi H, Abbasinejad M, Asadi A.

Arch Iran Med. 2017 Nov 1;20(11 Suppl. 1):S2-S6.

PMID:
29481116
3.

Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial.

Kashani L, Esalatmanesh S, Eftekhari F, Salimi S, Foroughifar T, Etesam F, Safiaghdam H, Moazen-Zadeh E, Akhondzadeh S.

Arch Gynecol Obstet. 2018 Mar;297(3):717-724. doi: 10.1007/s00404-018-4655-2. Epub 2018 Jan 13.

PMID:
29332222
4.

Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial.

Esalatmanesh S, Biuseh M, Noorbala AA, Mostafavi SA, Rezaei F, Mesgarpour B, Mohammadinejad P, Akhondzadeh S.

Iran J Psychiatry. 2017 Jul;12(3):154-162.

5.

Physical Activity Patterns in the Elderly Kashan Population.

Sadrollahi A, Hosseinian M, Masoudi Alavi N, Khalili Z, Esalatmanesh S.

Iran Red Crescent Med J. 2016 May 16;18(6):e25008. doi: 10.5812/ircmj.25008. eCollection 2016 Jun.

6.

Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.

Esalatmanesh S, Abrishami Z, Zeinoddini A, Rahiminejad F, Sadeghi M, Najarzadegan MR, Shalbafan MR, Akhondzadeh S.

Psychiatry Clin Neurosci. 2016 Nov;70(11):517-526. doi: 10.1111/pcn.12430. Epub 2016 Sep 29.

7.

The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double-blind and placebo-controlled trial.

Iranpour N, Zandifar A, Farokhnia M, Goguol A, Yekehtaz H, Khodaie-Ardakani MR, Salehi B, Esalatmanesh S, Zeionoddini A, Mohammadinejad P, Zeinoddini A, Akhondzadeh S.

Hum Psychopharmacol. 2016 Mar;31(2):103-12. doi: 10.1002/hup.2517. Epub 2016 Feb 8.

PMID:
26856695

Supplemental Content

Loading ...
Support Center